|
|
|
|
Effect of Primary Elvitegravir Resistance Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness
|
|
|
Reported by Jules Levin
International Workshop on HIV &
Hepatitis Virus Drug Resistance and Curative Strategies
June 5-9, 2012, Sitges, Spain
ME Abram, RM Hluhanich, DD Goodman, KN Andreatta, NA Margot, L Ye,
J Cavanaugh, A Niedziela-Majka, T Barnes, N Novikov, X Chen, ES Svarovskaia, DJ McColl, KL White and MD Miller
Gilead Sciences, Inc., California, USA
|
|
|
|
|
|
|